14 results
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
15 Apr 24
Report of Foreign Private Issuer
4:01pm
Abtretungserklärung (Zession) ist ausgeschlossen.
The transfer of intermediated securities based on the Company’s shares and the pledging
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
14 Mar 24
Report of Foreign Private Issuer
9:00am
Abtretungserklärung (Zession) ist ausgeschlossen.
The transfer of intermediated securities based on the Company’s shares and the pledging
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
13 Dec 22
Report of Foreign Private Issuer
7:31pm
schriftliche Abtretungserklärung (Zession) ist ausgeschlossen.
The transfer of intermediated securities based on the Company’s shares and the pledging
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
28 Oct 22
Report of Foreign Private Issuer
4:00pm
schriftliche Abtretungserklärung (Zession) ist ausgeschlossen.
The transfer of intermediated securities based on the Company’s shares and the pledging
6-K
EX-3.1
NLSP
NLS Pharmaceutics Ltd
7 Oct 22
Report of Foreign Private Issuer
4:01pm
Abtretungserklärung (Zession) ist ausgeschlossen.
The transfer of intermediated securities based on the Company’s shares and the pledging of these intermediated
6-K
EX-3.1
r6nrj4hrs9
16 Sep 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-3.1
c091xrveau1ghjtysjj
3 Jun 22
Report of Foreign Private Issuer
5:00pm
6-K
EX-3.1
pcnnp
14 Dec 21
Report of Foreign Private Issuer
4:59pm
6-K
EX-3.1
bzaut nq4u
23 Nov 21
Report of Foreign Private Issuer
7:11am
6-K
EX-3.1
xikrpbpl6c6a
26 Oct 21
Report of Foreign Private Issuer
4:00pm
6-K
EX-3.1
8rbyy1 qyu6849
9 Feb 21
Report of Foreign Private Issuer
12:00am
6-K
EX-3.2
2ctst8 5zuglkm9
9 Feb 21
Report of Foreign Private Issuer
12:00am
6-K
EX-3.1
r12sdvm6n
2 Feb 21
NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public Offering
5:29pm
F-1/A
EX-3.1
170580d
16 Oct 20
Registration statement (foreign) (amended)
9:59pm
- Prev
- 1
- Next